Investor Alert

Dow Jones Newswires Archives | Email alerts

Dec. 9, 2019, 4:09 a.m. EST

Roche extends tender offer for Spark Therapeutics

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Roche Holding AG (ROG)
  • X
    Spark Therapeutics Inc. (ONCE)

or Cancel Already have a watchlist? Log In

By Kim Richters

Spark Therapeutics

Roche Holding AG said Monday that it has extended the offer period for its planned takeover of biotechnology company Spark Therapeutics Inc. to Dec. 16.

Roche said the offer was extended to provide additional time for the U.S. Federal Trade Commission and the U.K. Competition and Markets Authority to complete their reviews of the pending acquisition.

The period for Roche’s /zigman2/quotes/206324342/delayed CH:ROG +2.18% offer of $114.50 per share has been extended several times and was set to expire on Dec. 10.

As of Dec. 6, around 14.9% of Spark’s /zigman2/quotes/200464619/composite ONCE +2.55%  outstanding shares had been tendered, according to Roche.

CH : Switzerland: SWX
CHF 327.95
+7.00 +2.18%
Volume: 3.27M
Jan. 17, 2020 5:31p
P/E Ratio
Dividend Yield
Market Cap
CHF280.75 billion
Rev. per Employee
US : U.S.: Nasdaq
$ 113.57
+2.82 +2.55%
Volume: 23,897
Dec. 16, 2019 4:00p
P/E Ratio
Dividend Yield
Market Cap
$4.29 billion
Rev. per Employee

Get news alerts on Spark Therapeutics Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

World News from MarketWatch

Link to MarketWatch's Slice.